NCT00745030 Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism Status TERMINATED Phase NA
NCT00744627 Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults. Status COMPLETED Phase PHASE3
NCT00739024 A Study of a Melatonin Receptor Agonist to Prevent Migraine Status TERMINATED Phase PHASE2
NCT00738725 BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population Status COMPLETED Phase N/A
NCT00737347 Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone Status COMPLETED Phase PHASE3
NCT00735709 Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00734071 An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder Status COMPLETED Phase PHASE3
NCT00731120 Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder Status COMPLETED Phase PHASE3
NCT00730691 Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder Status COMPLETED Phase PHASE3
NCT00727857 Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE3
NCT00724542 Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease. Status UNKNOWN Phase NA
NCT00722917 Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus Status TERMINATED Phase PHASE2
NCT00708175 Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose. Status COMPLETED Phase PHASE4
NCT00707993 Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics Status COMPLETED Phase PHASE3
NCT00707980 Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00696436 An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension. Status COMPLETED Phase PHASE3
NCT00696384 A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension Status COMPLETED Phase PHASE3
NCT00696241 Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension Status COMPLETED Phase PHASE3
NCT00695955 One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension Status COMPLETED Phase PHASE3
NCT00680043 Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA Status COMPLETED Phase PHASE2